QDVG.DE vs. 2B70.DE
Compare and contrast key facts about iShares S&P 500 Health Care Sector UCITS ETF (Acc) (QDVG.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE).
QDVG.DE and 2B70.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. QDVG.DE is a passively managed fund by iShares that tracks the performance of the S&P 500 Capped 35/20 Health Care. It was launched on Nov 20, 2015. 2B70.DE is a passively managed fund by iShares that tracks the performance of the Nasdaq Biotechnology. It was launched on Oct 19, 2017. Both QDVG.DE and 2B70.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: QDVG.DE or 2B70.DE.
Key characteristics
| QDVG.DE | 2B70.DE | |
|---|---|---|
| YTD Return | 14.79% | 11.40% |
| 1Y Return | 15.40% | 18.21% |
| 3Y Return (Ann) | 8.83% | -0.28% |
| 5Y Return (Ann) | 12.54% | 8.41% |
| Sharpe Ratio | 1.49 | 1.16 |
| Daily Std Dev | 10.64% | 16.99% |
| Max Drawdown | -26.77% | -30.87% |
| Current Drawdown | -1.43% | -3.14% |
Correlation
The correlation between QDVG.DE and 2B70.DE is 0.71, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
QDVG.DE vs. 2B70.DE - Performance Comparison
In the year-to-date period, QDVG.DE achieves a 14.79% return, which is significantly higher than 2B70.DE's 11.40% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
QDVG.DE vs. 2B70.DE - Expense Ratio Comparison
QDVG.DE has a 0.15% expense ratio, which is lower than 2B70.DE's 0.35% expense ratio.
Risk-Adjusted Performance
QDVG.DE vs. 2B70.DE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares S&P 500 Health Care Sector UCITS ETF (Acc) (QDVG.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
QDVG.DE vs. 2B70.DE - Dividend Comparison
Neither QDVG.DE nor 2B70.DE has paid dividends to shareholders.
Drawdowns
QDVG.DE vs. 2B70.DE - Drawdown Comparison
The maximum QDVG.DE drawdown since its inception was -26.77%, smaller than the maximum 2B70.DE drawdown of -30.87%. Use the drawdown chart below to compare losses from any high point for QDVG.DE and 2B70.DE. For additional features, visit the drawdowns tool.
Volatility
QDVG.DE vs. 2B70.DE - Volatility Comparison
The current volatility for iShares S&P 500 Health Care Sector UCITS ETF (Acc) (QDVG.DE) is 2.84%, while iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a volatility of 4.39%. This indicates that QDVG.DE experiences smaller price fluctuations and is considered to be less risky than 2B70.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.